LC-MS Peptide Analysis: How Mass Spectrometry Confirms Peptide Identity

LC-MS (liquid chromatography-mass spectrometry) separates the components of a sample by HPLC and passes each one straight into a mass spectrometer, which measures the mass-to-charge ratio (m/z) of its ions. For a peptide, that gives two independent pieces of evidence in one run: a retention time and a measured mass that can be compared with the value calculated from the sequence, often to within a few parts per million on a high-resolution instrument. Adding a fragmentation step (LC-MS/MS) breaks the peptide along its backbone and confirms the order of its residues, not just their total.

This article explains each step, with worked numbers, and ends with what the identity line on a peptide lab report does and does not establish.

LC-MS at a glance

Source: references 1 to 3; accuracy ranges are typical instrument specifications, not values from a single study.

How LC-MS works: separation first

The LC half is the same reversed-phase chromatography used for purity testing, described in our explainer on HPLC peptide purity. The difference is the detector. Instead of measuring UV absorbance, the column outlet feeds the ion source of a mass spectrometer, which records a full mass spectrum every fraction of a second.

Separation matters even when the goal is identity. Impurities such as a deletion sequence or an oxidised form usually elute at a slightly different time from the target, so each gets its own spectrum instead of being mixed into one. Isomers with the same mass, which the mass spectrometer cannot separate, may still be resolved by the column.

The mobile phase has to suit both halves. Trifluoroacetic acid gives the sharpest peptide peaks, but it pairs strongly with protonated peptides and masks them from the electric fields of the ion source, which suppresses the signal [4]. Many LC-MS methods therefore use formic acid, or only a small amount of TFA. Our article on trifluoroacetic acid in peptides covers that trade-off.

Electrospray ionisation and multiply charged ions

A mass spectrometer can only weigh ions in a vacuum, so the peptide has to leave solution, become charged and enter the gas phase intact. Electrospray ionisation does this by applying a high voltage to the liquid as it leaves a fine capillary. The liquid breaks into charged droplets, the solvent evaporates, and the peptide ions are released carrying extra protons.

Fenn and colleagues, describing the method for large biomolecules in 1989, noted its distinguishing feature: coherent series of peaks whose ions are multiply charged, each differing by one charge from its neighbours. They reported spectra for proteins with molecular weights up to 130,000 [1]. Multiple charging is what brings large molecules into the m/z range of ordinary analysers.

The other common soft ionisation method, matrix-assisted laser desorption ionisation (MALDI), was shown by Karas and Hillenkamp in 1988 to ionise proteins above 10,000 daltons [5]. MALDI mostly produces singly charged ions and is usually run offline from a sample plate, so routine peptide identity testing with an HPLC front end uses ESI.

m/z and charge states: worked numbers

A mass spectrometer measures m/z, not mass. For a peptide of neutral monoisotopic mass M carrying z extra protons (1.00728 Da each):

m/z = (M + z × 1.00728) / z

Take the pentapeptide Tyr-Gly-Gly-Phe-Leu (YGGFL), a common mass spectrometry test peptide. Its residue masses (see our amino acid primer for the table) plus one water give a monoisotopic mass of 555.2693 Da:

Source: calculated by Vortex from monoisotopic residue masses and the proton mass.

The charge state can be read from the isotope pattern. Natural carbon is about 1.1% carbon-13, so each peptide ion appears as a cluster of peaks spaced 1.00335 Da apart in mass. On the m/z axis that spacing is divided by the charge: peaks about 1.0 apart mean z = 1, about 0.5 apart mean z = 2, about 0.33 apart mean z = 3. The first peak of the cluster is the monoisotopic ion. For larger peptides the second or third peak becomes the tallest, so picking the wrong one is a classic error of about 1 Da.

Deconvolution: from a charge-state series to one mass

Larger peptides appear as a series of peaks, one for each charge state. Two neighbouring peaks are enough to work out both the charge and the mass. If m1 is the higher-m/z peak with charge z and m2 is the next peak with charge z + 1:

z = (m2 – 1.00728) / (m1 – m2), then M = z × (m1 – 1.00728)

Worked example for a hypothetical 25-residue peptide: peaks at m/z 949.1739 and 712.1323 give z = 711.1250 / 237.0416 = 3.000, so m1 is the 3+ ion and M = 3 × 948.1666 = 2,844.50 Da. The 2+ ion would appear at 1,423.26 and the 5+ at 569.91.

Software does this across the whole spectrum, a step called deconvolution, and usually combines it with deisotoping, which collapses each isotope cluster to one monoisotopic value. Open-source packages such as Decon2LS include peak finding, theoretical isotope-distribution modelling and deisotoping for high-resolution LC-MS data [6]. The result on a report is often a single “deconvoluted mass” in place of a list of m/z values.

Mass accuracy, and what mass alone cannot tell

Mass error is usually given in parts per million:

error (ppm) = (observed – calculated) / calculated × 10⁶

An observed [M+H]⁺ of 556.2779 against a calculated 556.2766 is an error of +2.3 ppm. On a high-resolution instrument that is a close match. On a unit-resolution quadrupole, a reading of 556.3 is the best the instrument can give, and it is consistent with the target but also with anything else within a few tenths of a dalton.

Even a perfect intact mass has blind spots:

• Same composition, different order. YGGFL and LFGGY have identical masses.
• Isobaric residues. Leucine and isoleucine have the same formula. Glutamine and lysine differ by only 0.036 Da, which a low-resolution instrument cannot see.
• Stereoisomers. A peptide with one D residue has exactly the same mass as the all-L form. Only chromatography or chiral methods separate them.
• Small modifications near the tolerance. Deamidation adds 0.984 Da, which falls on the next isotope peak, so a deamidated impurity can be mistaken for the target’s own isotope pattern at low resolution.

That is why intact mass is read together with retention time, and why order is confirmed by fragmentation.

MS/MS fragmentation: b and y ions

In tandem mass spectrometry, one precursor ion is selected, energised and broken, and the fragments are measured. With collision-induced dissociation, peptides break mostly at the amide bonds of the backbone. Each break gives two pieces. If the charge stays on the N-terminal piece it is a b ion; if it stays on the C-terminal piece it is a y ion. The naming system was proposed by Roepstorff and Fohlman in 1984 [7] and later set out in its common form by Biemann [8].

Reading the gaps between consecutive b ions, or consecutive y ions, gives the residue masses in order. For YGGFL:

Source: calculated by Vortex for singly charged ions from monoisotopic residue masses. Each b and y pair adds up to the [M+H]⁺ value plus one proton (557.2839).

The b4 to b3 gap is 147.068, the residue mass of phenylalanine, so phenylalanine sits at position 4. LFGGY would give a completely different ladder, which is how MS/MS separates sequences that intact mass cannot.

Fragmentation is not perfectly even. Wysocki and colleagues explained the patterns with the mobile proton model: for many peptides cleavage at the amide bonds dominates and gives b and y series, but when the charge is not available to the backbone, cleavage is enhanced on the C-terminal side of aspartic or glutamic acid. Cleavage is also enhanced at histidine when its side chain is protonated [9]. Electron-based methods break different bonds. Electron capture dissociation, described by Zubarev and colleagues, cleaves many more backbone bonds than collisional methods, and modifications are less easily lost [3]. Electron transfer dissociation, introduced by Syka and colleagues in 2004, brings the same kind of fragmentation to ion-trap instruments using anions to deliver the electron [2].

Steen and Mann’s review gives an accessible walk-through of how these spectra are read back into a sequence [10].

Peptide mapping

For proteins and long peptides, MS/MS of the intact molecule is impractical. Peptide mapping solves this. The protein is cut with a specific enzyme, most often trypsin, which cleaves after lysine and arginine. The resulting peptides are separated by LC and each is identified by its mass and fragments. The map, a chromatogram with every peak assigned, is compared with a reference.

Hunt and colleagues laid out the approach in 1986. They degraded a protein enzymatically and chemically, fractionated the peptides by HPLC, and analysed fractions holding as many as 10 to 15 peptides directly by tandem mass spectrometry, without further purification [11]. Retention prediction now helps assign peaks. Krokhin and colleagues built a model from 346 tryptic peptides and used it to tell apart peptides with close m/z values and for detailed peptide mapping [12]. TFA’s signal suppression was an early obstacle here too, and post-column additives were developed specifically to make LC-MS peptide maps more sensitive [13].

Peptide mapping is described by name in quality guidance such as ICH Q6B and the USP general chapter on peptide mapping. For a short synthetic peptide of under about 30 residues, the full sequence is usually confirmed directly from intact mass plus MS/MS, and enzymatic mapping adds little.

Edman degradation: the historical method

Before tandem MS, sequence was read chemically. In Edman degradation, phenyl isothiocyanate couples to the free N-terminal amine. Anhydrous acid then cleaves off only that first residue as a cyclic derivative, which is converted to a stable phenylthiohydantoin (PTH) amino acid and identified by chromatography. The shortened chain is left ready for the next round. Edman and Begg automated the process in 1967 with their protein sequenator [14].

Edman sequencing reads residues directly from the N-terminus and needs no reference mass list, which is why it was the standard for decades. Its limits explain why MS largely replaced it:

• It cannot start on a blocked N-terminus, such as an acetylated peptide or a pyroglutamate.
• Each round is slightly less than complete, so signals blur after a few dozen residues.
• It has no N-terminus to start from on a head-to-tail cyclic peptide.
• It reads one residue at a time and needs a relatively pure sample.

It is still used where an independent chemical read of the N-terminus is wanted, for example to confirm an expected N-terminal sequence.

What an identity line on a COA means

On a peptide certificate of analysis, the identity line says which method was used and whether the result matched. Two published Vortex reports, discussed in detail in our explainer on how to read a peptide COA, show the two common forms:

Source: lab reports published at /coa/; masses calculated by Vortex.

Mass confirmation is the stronger identity test, because two different peptides rarely share both a retention time and an exact mass. Retention matching is useful but depends on the reference standard and can be shared by closely related molecules. Neither form, on its own, confirms residue order; that needs MS/MS.

When reading an LC-MS identity line, check for:

• The expected value. The calculated mass or m/z should be stated, with the charge state if an m/z is given.
• The observed value. A bare “conforms” is less informative than the measured number.
• Monoisotopic or average. For a 2,800 Da peptide the two differ by nearly 2 Da, so the report should say which is being compared.
• Tolerance. A match within 0.5 Da on a quadrupole and a match within 5 ppm on a high-resolution instrument are different levels of evidence.
• Whether MS/MS was run. If the report includes fragment ions, it has confirmed sequence, not just composition.

Our primer on what a COA is covers the rest of the document.

Frequently asked questions

What is LC-MS and how does it work?

LC-MS is liquid chromatography coupled to mass spectrometry. The HPLC column separates the sample, and the outlet feeds an ion source, usually electrospray, that turns each component into gas-phase ions. The mass spectrometer then measures their mass-to-charge ratio, giving a retention time and a measured mass for every peak.

What are b and y ions in peptide mass spectrometry?

They are the two kinds of fragment formed when a peptide ion breaks at a backbone amide bond in MS/MS. A b ion keeps the N-terminal end and a y ion keeps the C-terminal end. The mass gaps between consecutive b or y ions equal the residue masses, so the series reads out the sequence in order.

What is peptide mapping?

Peptide mapping is a method for confirming the sequence of a protein or long peptide. The molecule is cut with a specific enzyme such as trypsin, the fragments are separated by LC and identified by mass spectrometry, and the resulting map is compared with what the expected sequence predicts.

Is Edman degradation still used?

Edman degradation, which removes and identifies one N-terminal residue at a time, has largely been replaced by tandem mass spectrometry. It is still used for an independent chemical read of an N-terminal sequence. It cannot read past a blocked N-terminus, and its signal fades after a few dozen residues.

Research materials: Vortex supplies peptides as sealed lyophilised research reagents. Browse the catalogue at /shop/. Published lab reports are at /coa/.

References

1. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246(4926):64-71. PMID 2675315. doi:10.1126/science.2675315
2. Syka JE, Coon JJ, Schroeder MJ, Shabanowitz J, Hunt DF. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci U S A. 2004;101(26):9528-33. PMID 15210983. doi:10.1073/pnas.0402700101
3. Zubarev RA, Horn DM, Fridriksson EK, et al. Electron capture dissociation for structural characterization of multiply charged protein cations. Anal Chem. 2000;72(3):563-73. PMID 10695143. doi:10.1021/ac990811p
4. Kuhlmann FE, Apffel A, Fischer SM, Goldberg G, Goodley PC. Signal enhancement for gradient reverse-phase high-performance liquid chromatography-electrospray ionization mass spectrometry analysis with trifluoroacetic and other strong acid modifiers by postcolumn addition of propionic acid and isopropanol. J Am Soc Mass Spectrom. 1995;6(12):1221-5. PMID 24214073. doi:10.1016/1044-0305(95)00571-4
5. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem. 1988;60(20):2299-301. PMID 3239801. doi:10.1021/ac00171a028
6. Jaitly N, Mayampurath A, Littlefield K, Adkins JN, Anderson GA, Smith RD. Decon2LS: an open-source software package for automated processing and visualization of high resolution mass spectrometry data. BMC Bioinformatics. 2009;10:87. PMID 19292916. doi:10.1186/1471-2105-10-87
7. Roepstorff P, Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed Mass Spectrom. 1984;11(11):601. PMID 6525415. doi:10.1002/bms.1200111109
8. Biemann K. Appendix 5. Nomenclature for peptide fragment ions (positive ions). Methods Enzymol. 1990;193:886-7. PMID 2074849. doi:10.1016/0076-6879(90)93460-3
9. Wysocki VH, Tsaprailis G, Smith LL, Breci LA. Mobile and localized protons: a framework for understanding peptide dissociation. J Mass Spectrom. 2000;35(12):1399-406. PMID 11180630
10. Steen H, Mann M. The ABC’s (and XYZ’s) of peptide sequencing. Nat Rev Mol Cell Biol. 2004;5(9):699-711. PMID 15340378. doi:10.1038/nrm1468
11. Hunt DF, Yates JR 3rd, Shabanowitz J, Winston S, Hauer CR. Protein sequencing by tandem mass spectrometry. Proc Natl Acad Sci U S A. 1986;83(17):6233-7. PMID 3462691. doi:10.1073/pnas.83.17.6233
12. Krokhin OV, Craig R, Spicer V, Ens W, Standing KG, Beavis RC, Wilkins JA. An improved model for prediction of retention times of tryptic peptides in ion pair reversed-phase HPLC: its application to protein peptide mapping by off-line HPLC-MALDI MS. Mol Cell Proteomics. 2004;3(9):908-19. PMID 15238601. doi:10.1074/mcp.M400031-MCP200
13. Apffel A, Fischer S, Goldberg G, Goodley PC, Kuhlmann FE. Enhanced sensitivity for peptide mapping with electrospray liquid chromatography-mass spectrometry in the presence of signal suppression due to trifluoroacetic acid-containing mobile phases. J Chromatogr A. 1995;712(1):177-90. PMID 8556150. doi:10.1016/0021-9673(95)00175-m
14. Edman P, Begg G. A protein sequenator. Eur J Biochem. 1967;1(1):80-91. PMID 6059350

Methods note: written by the Vortex Research Editorial Team. Literature was selected from PubMed for analytical chemistry topics, every PMID was checked against its PubMed record for title, journal and year, and each abstract (where PubMed holds one) was read against the sentence that cites it. All m/z values were calculated from monoisotopic residue masses. ICH Q6B and the USP peptide mapping chapter are cited by name.

Vortex Research products are sold for in-vitro laboratory research by qualified researchers. Not for human or veterinary use. Not a drug, dietary supplement or cosmetic. Statements have not been evaluated by the FDA.